Latest News

COMMENTARY: Treating Liver Disease During COVID-19: New Recommendations

Guidance from the AASLD comes with a disclaimer but still offers valuable insights to clinicians, says Dr William F. Balistreri.

Source link

Related posts

EU Temporarily Authorizes Sale Of Remdesivir To Treat COVID-19 Patients


TAZVERIK™ (Tazemetostat) Approved for the Treatment of Epithelioid Sarcoma, Available from Onco360®


Alnylam Announces Settlement of Litigation with Silence Therapeutics


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World